Interpreting the PISCES Trial on Fish Oil in Hemodialysis Patients: Lessons on Trial Design, Biological Exposure, and Outcome Measurement doi.org/10.1093/ckj/...
Clinical Kidney Journal
@ckj-era.bsky.social
Clinical Kidney Journal is the online open access journal of the European Renal Association published by Oxford University Press.
Liver fraction of circulating alkaline phosphatase is elevated in chronic kidney disease and associates with mortality in patients treated with hemodialysis doi.org/10.1093/ckj/...
Erythroferrone is associated with the hepcidin-to-ferritin ratio and cardiovascular mortality in chronic kidney disease doi.org/10.1093/ckj/...
Constipation Prevalence and Its Association With Kidney Function: A Large Nationwide Japanese Health Check-Up Cohort Study doi.org/10.1093/ckj/...
Constipation Prevalence and Its Association With Kidney Function: A Large Nationwide Japanese Health Check-Up Cohort Study
AbstractBackground. Constipation is one of the most common gastrointestinal disorders in the general population. However, its prevalence in patients with c
doi.org
Beyond expensive innovations: affordable and effective strategies for managing tubulopathies in adults doi.org/10.1093/ckj/...
Beyond expensive innovations: affordable and effective strategies for managing tubulopathies in adults
ABSTRACT. Tubulopathies comprise a heterogeneous and still poorly defined group of inherited and acquired disorders in which tubular transport is dispropor
doi.org
🤩 Check out the new March issue of CKJ! academic.oup.com/ckj/issue/19/3
Volume 19 Issue 3 | Clinical Kidney Journal | Oxford Academic
The official open access journal of the European Renal Association - European Dialysis Transplant Association. It is an essential educational and training resource integrating clinical, translational,...
academic.oup.com
A case of adrenal insufficiency after initiation of targeted release budesonide formulation (Nefecon) in a Patient with IgA nephropathy doi.org/10.1093/ckj/...
A case of adrenal insufficiency after initiation of targeted release budesonide formulation (Nefecon) in a Patient with IgA nephropathy
Abstract. We describe a case of IgA nephropathy (IgAN) treated with targeted-release budesonide (Nefecon) that resulted in notable systemic adverse effects
doi.org
Turning major revision into opportunity: ten tips to navigate peer review after manuscript submission doi.org/10.1093/ckj/...
Turning major revision into opportunity: ten tips to navigate peer review after manuscript submission
Mythri Shankar, Mohamed Hassanein, Alexander Woywodt; Turning major revision into opportunity: ten tips to navigate peer review after manuscript submission
doi.org
Use of acetazolamide in volume overload: start at the beginning doi.org/10.1093/ckj/...
Use of acetazolamide in volume overload: start at the beginning
ABSTRACT. The treatment of volume overload has vexed physicians for centuries. References to herbal remedies for the treatment of fluid retention date as f
doi.org
The ERA Registry Annual Report 2022: Epidemiology of Kidney Replacement Therapy in Europe, with a focus on sex comparisons doi.org/10.1093/ckj/...
Role of lupus nephritis classification systems in everyday clinical practice: a questionnaire-based survey of the Renal Pathology Society (RPS) doi.org/10.1093/ckj/...
Role of lupus nephritis classification systems in everyday clinical practice: a questionnaire-based survey of the Renal Pathology Society (RPS)
AbstractBackground. Kidney biopsy is the gold standard for lupus nephritis (LN) diagnosis, with the 2018 International Society of Nephrology/Renal Patholog
doi.org
Targeting B cells in IgA nephropathy: from pathogenic insight to therapeutic horizon doi.org/10.1093/ckj/...
Targeting B cells in IgA nephropathy: from pathogenic insight to therapeutic horizon
ABSTRACT. Immunoglobulin A nephropathy (IgAN) remains the most common primary glomerulonephritis globally. Advances in mucosal immunology have illuminated
doi.org
Mechanism of reduced intestinal phosphate absorption by tenapanor: a hypothesis doi.org/10.1093/ckj/...
Mechanism of reduced intestinal phosphate absorption by tenapanor: a hypothesis
ABSTRACT. Tenapanor, a selective inhibitor of the sodium/hydrogen exchanger isoform 3 (NHE3), was initially developed for the treatment of irritable bowel
doi.org
Transformative global models for CKD care: case studies and strategies doi.org/10.1093/ckj/...
Transformative Global Models for CKD Care: Case Studies and Strategies
Abstract. Chronic kidney disease (CKD) affects approximately 10% of adults worldwide and is associated with an elevated risk of cardiovascular disease, suc
doi.org
Microscopic hematuria in IgA nephropathy: a biomarker of disease activity doi.org/10.1093/ckj/...
Microscopic hematuria in IgA nephropathy: a biomarker of disease activity
Abstract. Immunoglobulin A nephropathy (IgAN) is an immune-mediated disease of B-cell origin and the most common primary glomerulonephritis worldwide, whic
doi.org
Protocadherin FAT1-associated membranous nephropathy after hematopoietic stem cell transplantation – a cohort study with clinico-pathological correlations doi.org/10.1093/ckj/...
Protocadherin FAT1-associated membranous nephropathy after hematopoietic stem cell transplantation – a cohort study with clinico-pathological correlations
AbstractBackground. The identification of causative antigens for membranous nephropathy (MN) has revolutionized the comprehension of the pathophysiology of
doi.org
Impact of dapagliflozin on bone mineral metabolism in non-diabetic patients with chronic kidney disease: a randomized, double-blind, placebo-controlled study doi.org/10.1093/ckj/...
Impact of dapagliflozin on Bone Mineral Metabolism in Non-diabetic patients with chronic kidney disease: a randomized, double-blind, placebo-controlled study
AbstractBackground. SGLT2i have demonstrated reno-protective effects in patients with CKD. However, concerns remain regarding their potential effect on bon
doi.org
Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis doi.org/10.1093/ckj/...
Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease doi.org/10.1093/ckj/...
Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease
ABSTRACT. Sex (biologically determined) and gender (socially constructed) modulate manifestations and prognosis of a vast number of diseases, including car
doi.org
Antidepressant prescriptions by provider in patients with kidney failure and depression doi.org/10.1093/ckj/...
Antidepressant prescriptions by provider in patients with kidney failure and depression
AbstractBackground. The prevalence of depression is high among patients with end-stage kidney disease (ESKD). Recent studies have indicated under-recogniti
doi.org
Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillation doi.org/10.1093/ckj/...
Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillation
ABSTRACT. Patients with chronic kidney disease (CKD) have a high incidence and prevalence of atrial fibrillation (AF). While general treatment strategies f
doi.org
Remote ischemic preconditioning for prevention of contrast-associated acute kidney injury following percutaneous coronary intervention: a randomized controlled trial doi.org/10.1093/ckj/...
Clinical and genetic features of Gitelman syndrome patients with hyperuricemia doi.org/10.1093/ckj/...
Clinical and genetic features of Gitelman syndrome patients with hyperuricemia
ABSTRACTBackground. Gitelman syndrome (GS) is a rare inherited salt-losing tubulopathy caused by dysfunction of the thiazide-sensitive sodium-chloride cotr
doi.org
Cardiac Impact of dapagliflozin in advanced chronic kidney disease: rationale and design of the Renal Lifecycle trial cardiac imaging sub-studies doi.org/10.1093/ckj/...
Cardiac Impact of Dapagliflozin in Advanced Chronic Kidney Disease: Rationale and Design of the Renal Lifecycle Trial Cardiac Imaging Sub-studies
AbstractBackground. Patients with chronic kidney disease (CKD) are frequently hospitalized for heart failure. Sodium glucose co-transporter 2 (SGLT2)-inhib
doi.org